Physician profile
Troy D Bracker
NPI 1053369900
$2,980.22
in general payments reported to CMS, 2019-2025
33 companies · $697 in 2025
The $697 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $61.74 · 2021: $281 · 2022: $670 · 2023: $834 · 2024: $437 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,967.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $670.14 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $469.27 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $344.32 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Pfizer INC. | $291.62 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $150.46 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $136.07 | 2021-2025 | Invega Sustenna, Xarelto, Spravato |
| Astrazeneca Pharmaceuticals LP | $111.84 | 2020-2024 | Airsupra, Farxiga |
| Abbott Laboratories | $102.29 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Axsome Therapeutics, INC. | $58.61 | 2023-2025 | Sunosi |
| Biohaven Pharmaceutical Holding Company LTD. | $51.49 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $49.24 | 2021-2024 | Rexulti |
| Astellas Pharma US INC | $47.39 | 2021-2024 | Veozah, Myrbetriq |
| Sanofi-Aventis U.S. LLC | $44.18 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $40.92 | 2021-2022 | |
| Amgen INC. | $39.16 | 2022-2025 | Evenity, Otezla, Repatha |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $35.42 | 2023 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.87 | 2023-2024 | |
| Exact Sciences Corporation | $28.32 | 2023-2024 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $27.61 | 2022 | |
| Genentech USA, INC. | $26.55 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.98 | 2025 | Caplyta |
| Bausch Health US, LLC | $20.35 | 2022 | |
| Inspire Medical Systems, INC. | $19.11 | 2025 | Inspire |
| Antares Pharma, INC. | $18.98 | 2024 | Xyosted |
| Biohaven Pharmaceuticals, INC. | $18.38 | 2021 | |
| Ardelyx, INC. | $17.98 | 2025 | Ibsrela |
| Grifols USA, LLC | $17.49 | 2023 | Prolastin-C Liquid |
| Neos Therapeutics, LP | $17.19 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.03 | 2023 | |
| Phathom Pharmaceuticals, INC. | $15.80 | 2025 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $14.10 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.34 | 2023 | Quviviq |
| Jazz Pharmaceuticals INC. | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Bracker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.